Design, Synthesis, and Biological Evaluation of Arylimidazole Derivatives as Potent PPARδ Agonists for the Treatment of Renal Fibrosis
- DOI
- 10.1021/acs.jmedchem.5c03132
- Published
- 2026-02-10
- Container
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.5c03132,
title = {Design, Synthesis, and Biological Evaluation of Arylimidazole Derivatives as Potent PPARδ Agonists for the Treatment of Renal Fibrosis},
author = {Zhiqi Feng and Junkai Xie and Dongliang Hou and Zhuoxin Fu and Suyang Sun and Xinpeng Liu and Gang Sun and Runan Zheng and Liu Liu and Qinglong Xu and Xiaoan Wen and Daoxu Zhang and Haoliang Yuan and Hongbin Sun and Liang Dai},
year = {2026},
journal = {Journal of Medicinal Chemistry},
doi = {10.1021/acs.jmedchem.5c03132},
url = {https://doi.org/10.1021/acs.jmedchem.5c03132}
}RIS
TY - JOUR TI - Design, Synthesis, and Biological Evaluation of Arylimidazole Derivatives as Potent PPARδ Agonists for the Treatment of Renal Fibrosis AU - Zhiqi Feng AU - Junkai Xie AU - Dongliang Hou AU - Zhuoxin Fu AU - Suyang Sun AU - Xinpeng Liu AU - Gang Sun AU - Runan Zheng AU - Liu Liu AU - Qinglong Xu AU - Xiaoan Wen AU - Daoxu Zhang AU - Haoliang Yuan AU - Hongbin Sun AU - Liang Dai PY - 2026 JO - Journal of Medicinal Chemistry DO - 10.1021/acs.jmedchem.5c03132 UR - https://doi.org/10.1021/acs.jmedchem.5c03132 ER -
APA
Feng, Z., Xie, J., Hou, D., Fu, Z., Sun, S., Liu, X., Sun, G., Zheng, R., Liu, L., Xu, Q., Wen, X., Zhang, D., Yuan, H., Sun, H., & Dai, L. (2026). Design, Synthesis, and Biological Evaluation of Arylimidazole Derivatives as Potent PPARδ Agonists for the Treatment of Renal Fibrosis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03132
Source records
- crossref · retrieved 2026-09-26T12:12:35.806Z